#19:  Coffee's impact on blood pressure, safety of carotid artery stenting in the real world, transcatheter aortic-valve replacement in patients with coronary artery disease

#19: Coffee's impact on blood pressure, safety of carotid artery stenting in the real world, transcatheter aortic-valve replacement in patients with coronary artery disease

Ready to dig into the latest cardiology research? In less than 15 minutes, we'll give you the low-down on three new studies that'll help you in clinical practice.

STUDY #1: First, we explore safety outcomes for carotid artery stenting and see how this could impact your clinical discussions and decision-making. And if you practice in the U.S., now that Medicare and Medicaid cover this procedure for a broader range of patients, this info will prove to be especially important.

Uchida, K, Sakakibara, F, Sakai, N, et al. 2024. Real-world outcomes of carotid artery stenting in symptomatic and asymptomatic patients with carotid artery stenosis. JACC Cardiovasc Interv. 9: 1160-1162. (https://doi.org/10.1016/j.jcin.2024.03.014)

STUDY #2: Next, we tackle a common cardiology conundrum: how should we handle significant coronary artery disease lesions discovered incidentally in patients with severe aortic stenosis who are undergoing transcatheter aortic valve replacement? Is it better to treat these lesions beforehand, or is there a better strategy? We'll probe the debate, highlighting the potential implications of this new data.

Colaiori, I, Paolucci, L, Mangiacapra, F, et al. 2024. Natural history of coronary atherosclerosis in patients with aortic stenosis undergoing transcatheter aortic valve replacement: The role of quantitative flow ratio. Circ Cardiovasc Interv. 0: e013705. (https://doi.org/10.1161/CIRCINTERVENTIONS.123.013705)

STUDY #3: Lastly, we sip our way through the nuances of coffee consumption and its impact on blood pressure and cardiac arrhythmias. A new study lets us know whether our patients' daily caffeine fix can be left off the list of cardiac concerns.

Trevano, F, Vela-Bernal, S, Facchetti, R, et al. 2024. Habitual coffee consumption and office, home, and ambulatory blood pressure: Results of a 10-year prospective study. J Hypertens. 6: 1094-1100. (https://doi.org/10.1097/HJH.0000000000003709)

Join us to break down these studies, and elevate your cardiology knowledge!

Learn more with these courses:

Coronary Angiography Essentials (3 CME)

Coronary Angiography Essentials Workshop (1 CME)

Get a Basic or Pro account, or, get a Trial account.

Show notes:

Visit us at https://www.medmastery.com/podcasts/cardiology-podcast.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(25)

#25: Influenza and myocardial infarction, fasting protocols for cath lab procedures, anticoagulation therapy and transcatheter aortic-valve replacement

#25: Influenza and myocardial infarction, fasting protocols for cath lab procedures, anticoagulation therapy and transcatheter aortic-valve replacement

In today's episode of Cardiology Digest, we look at three recent research papers that can impact your clinical practice. They're from NEJM Evidence, the European Heart Journal, and The New England Jou...

8 Loka 202410min

#24: Patient selection and antiplatelet therapy for percutaneous coronary intervention (PCI), the best anticoagulants for patients with atrial fibrillation

#24: Patient selection and antiplatelet therapy for percutaneous coronary intervention (PCI), the best anticoagulants for patients with atrial fibrillation

In this episode of Medmastery's Cardiology Digest, we dive into three groundbreaking studies that are set to reshape our understanding and approach to cardiology. STUDY #1: First, we discuss a landmar...

24 Syys 202411min

#23: Edoxaban dosage and atrial fibrillation, invasive vs. noninvasive treatment of NSTEMI, chelation therapy for coronary artery disease

#23: Edoxaban dosage and atrial fibrillation, invasive vs. noninvasive treatment of NSTEMI, chelation therapy for coronary artery disease

Stay ahead with the newest cardiology research findings that could change your clinical practice! STUDY #1: First up, we explore new data on edoxaban dosage for older patients with atrial fibrillation...

10 Syys 202410min

#22: Heart failure & rapid uptitration of neurohormonal blockade, home treatment for acute pulmonary embolism, cardiovascular outcomes after bariatric surgery for weight loss

#22: Heart failure & rapid uptitration of neurohormonal blockade, home treatment for acute pulmonary embolism, cardiovascular outcomes after bariatric surgery for weight loss

Welcome to the latest episode of Medmastery's Cardiology Digest, where In less than 15 minutes we'll get you up to date on breakthrough studies and advancements in cardiology that can impact your clin...

27 Elo 202412min

#21: Semaglutide and blindness, antihypertensive medications and eczematous dermatitis, the new PREVENT cardiovascular risk calculator

#21: Semaglutide and blindness, antihypertensive medications and eczematous dermatitis, the new PREVENT cardiovascular risk calculator

This week, we have three compelling research papers that are sure to expand your clinical acumen. STUDY #1: We explore the debate surrounding the new PREVENT calculator's impact on predictions of 10-y...

13 Elo 202412min

#20: Comparing 2 cryoballoons for ablation of paroxysmal atrial fibrillation, a high-risk subpopulation for transcatheter aortic valve replacement, hypertensive disorders in pregnancy

#20: Comparing 2 cryoballoons for ablation of paroxysmal atrial fibrillation, a high-risk subpopulation for transcatheter aortic valve replacement, hypertensive disorders in pregnancy

In this episode of Cardiology Digest, we dive into top journals like JAMA Cardiology to bring you three of the most compelling recent research papers from the field of cardiology. STUDY #1: First, see...

30 Heinä 202412min

#18: CHA2DS2-VASc scoring and anticoagulation for silent atrial fibrillation, race and renin-angiotensin system inhibition in HFrEF, V142I transthyretin gene variant and cardiovascular health

#18: CHA2DS2-VASc scoring and anticoagulation for silent atrial fibrillation, race and renin-angiotensin system inhibition in HFrEF, V142I transthyretin gene variant and cardiovascular health

In less than 15 minutes, Medmastery's Cardiology Digest will give you the low-down on some of the most compelling studies in cardiology that clinicians with an interest in cardiovascular health need t...

2 Heinä 202412min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
utelias-mieli
rss-hereilla
tiedekulma-podcast
hippokrateen-vastaanotolla
rss-kasvikutsut
university-of-eastern-finland
docemilia
rss-ruoka-murroksessa
rss-poliisin-mieli
rss-duodecim-lehti
vinkista-vihia
rss-jyvaskylan-yliopisto
rss-kasvatuspsykologiaa-kaikille
rss-yleislaakarin-sydanaanet
rss-lapsuuden-rakentajat-podcast
radio-antro
rss-ilmasto-kriisissa
rss-lihavuudesta-podcast
rss-tiedetta-vai-tarinaa